Stock 4568 DAIICHI SANKYO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 01:30:00 2025-02-07 am EST 		5-day change 1st Jan Change
3,833.00 JPY -0.47% Intraday chart for Daiichi Sankyo Co., Ltd. -10.38% -11.93%
Feb. 06 IHH Healthcare's damages against Daiichi could reach $1.25 billion, expert report says RE
Feb. 06 IHH's NTK Raises Claim Against Daiichi Sankyo to Up to 199.8 Billion Yen MT

Chart calendar Daiichi Sankyo Co., Ltd.

8910180f959bfd0f55422bc.1obhxy7phanDr1hsWxmkFEWzi3mqhUyAbJHjPxLWW1s.ntez8XG6ssOixgIKFHjoZxCE2x3Y0z3LLcKiWmelEReitdj3W5ru2PXaNw~2da4e2df8a5fadbda6cb611171b5627b

Upcoming events on Daiichi Sankyo Co., Ltd.

2025-03-27 Final dividend
2025-04-23 Q4 2025 Earnings Release (Projected)
2025-07-29 Q1 2025 Earnings Release (Projected)
2025-10-28 Q2 2025 Earnings Release (Projected)
2026-01-29 Q3 2025 Earnings Release (Projected)

Past events on Daiichi Sankyo Co., Ltd.

2025-01-30 Q3 2024 Earnings Call
2025-01-30 Q3 2024 Earnings Release
2025-01-13 07:30 pm JP Morgan Healthcare Conference
2024-12-16 05:30 pm R&D Day
2024-12-13 01:30 pm San Antonio Breast Cancer Symposium - Abstract Number: P5-07-29
2024-12-13 08:00 am San Antonio Breast Cancer Symposium - Abstract Number: PS14-10
2024-12-12 01:30 pm San Antonio Breast Cancer Symposium - Abstract Number: P3-09-20
2024-12-12 01:30 pm San Antonio Breast Cancer Symposium - Abstract Number: P3-12-28
2024-12-12 01:30 pm San Antonio Breast Cancer Symposium - Abstract Number: P3-08-24
2024-12-12 01:30 pm San Antonio Breast Cancer Symposium - Abstract Number: P3-08-21
2024-12-12 01:30 pm San Antonio Breast Cancer Symposium - Abstract Number: P3-09-17
2024-12-12 08:00 am San Antonio Breast Cancer Symposium - Abstract Number: PS8-03
2024-12-11 06:30 pm San Antonio Breast Cancer Symposium - Abstract Number: P2-08-27
2024-12-11 06:30 pm San Antonio Breast Cancer Symposium - Abstract Number: P2-12-20
2024-12-11 01:30 pm San Antonio Breast Cancer Symposium - Abstract Number: P1-02-10
2024-12-11 01:30 pm San Antonio Breast Cancer Symposium - Abstract Number: P1-03-28
2024-12-10 San Antonio Breast Cancer Symposium - Abstract Number: LBA1-06
2024-12-10 San Antonio Breast Cancer Symposium - Abstract Number: LB1-04
2024-12-09 09:00 pm American Society of Hematology Meeting - Abstract Number: 4342
2024-12-09 09:00 pm American Society of Hematology Meeting - Abstract Number: 4479

Past dividends on Daiichi Sankyo Co., Ltd.

2024-09-26 Interim Payment 30 JPY
2024-03-27 Final Payment 30 JPY
2023-09-27 Interim Payment 20 JPY
2023-03-29 Final Payment 15 JPY
2022-09-28 Interim Payment 15 JPY
2022-03-29 Final Payment 13.5 JPY
2021-09-28 Interim Payment 13.5 JPY
2021-03-29 Final Payment 13.5 JPY
2020-09-28 Interim Payment 40.5 JPY
2020-03-29 Final Payment 35 JPY
2019-09-26 Interim Payment 35 JPY
2019-03-26 Final Payment 35 JPY
2018-09-25 Interim Payment 35 JPY
2018-03-27 Final Payment 35 JPY
2017-09-26 Interim Payment 35 JPY
2017-03-28 Final Payment 35 JPY
2016-09-27 Interim Payment 35 JPY
2016-03-28 Final Payment 30 JPY
2015-09-27 Interim Payment 30 JPY
2015-09-27 Bonus Payment 10 JPY

Annual results

Fiscal PeriodMarch 2022 2023 2024 2025 2026 2027
Net sales
Million JPY		Released
Forecast
Spread 		1 044 900
1 034 624
0.99%		1 278 478
1 267 390
0.87%		1 601 700
1 580 154
1.36%
1 846 709


2 090 740


2 411 402

EBITDA
Million JPY		Released
Forecast
Spread 		131 270
155 362
-15.51%		188 369
191 173
-1.47%		271 234
251 664
7.78%
337 747


373 982


465 119

EBIT
Million JPY		Released
Forecast
Spread 		73 000
96 404
-24.28%		120 580
134 276
-10.2%		211 600
191 646
10.41%
286 279


334 636


454 168

Earnings before Tax (EBT)
Million JPY		Released
Forecast
Spread 		73 500
97 839
-24.88%		126 854
136 479
-7.05%		237 200
200 698
18.19%
298 389


341 698


458 973

Net income
Million JPY		Released
Forecast
Spread 		67 000
70 466
-4.92%		109 188
102 307
6.73%		200 700
167 864
19.56%
239 746


265 252


350 049

EPS
JPY		Released
Forecast
Spread 		34,9
36,5
-4.27%		57,0
53,1
7.33%		105
87,3
19.9%
127


147


188

Announcement Date27/04/2227/04/2325/04/24-

Quarterly results

Fiscal PeriodSeptember 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 S1 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 S1 2026 Q3 2026 Q4
Net sales
Million JPY		Released
Forecast
Spread 		330 202
314 825
4.88%		350 835
330 936
6.01%		375 465
369 692
1.56%		726 300
709 573
2.36%		446 925
406 519
9.94%		428 431
406 491
5.4%		436 175
409 987
6.39%		446 525
426 204
4.77%		882 700
819 936
7.65%		484 900
474 367
2.22%
489 708


449 668


512 700


885 531


554 500


625 500

EBITDA
Million JPY		Released
Forecast
Spread











114 454
87 200
31.25%		33 427
40 212
-16.87%		109 594
110 400
-0.73%


























EBIT
Million JPY		Released
Forecast
Spread 		-6 551
7 982
-182.07%		44 032
39 637
11.09%		51 068
35 618
43.38%		95 100
68 024
39.8%		99 488
51 269
94.05%		17 049
8 828
93.14%		92 979
57 200
62.55%		93 921
43 904
113.92%		186 900
83 652
123.43%		61 400
75 160
-18.31%
40 666


43 228





86 037







Earnings before Tax (EBT)
Million JPY		Released
Forecast
Spread 		-596
8 254
-107.22%		52 133
43 082
21.01%		49 967
8 400
494.85%		102 100
71 803
42.19%		97 749
-5 000
2054.98%		37 354
16 259
129.75%		110 198
61 129
80.27%		82 402
32 106
156.66%		192 600
89 302
115.67%		82 400
65 400
25.99%
35 199


43 228





80 352







Net income
Million JPY		Released
Forecast
Spread 		22 488
4 303
422.65%		57 013
32 400
75.97%		39 987
11 201
256.99%		97 000
58 677
65.31%		66 558
27 792
139.49%		37 136
16 199
129.25%		85 383
53 466
59.69%		61 317
41 657
47.19%		146 700
72 042
103.63%		61 900
55 827
10.88%
43 849


34 582





64 282







EPS
JPY		Released
Forecast
Spread 		11,7
0,90
1208.17%		29,7
16,2
83.75%		20,9
20,5
1.69%		50,6
34,3
47.49%		34,7
17,4
99.95%		19,4
7,56
156.2%		44,6
23,8
87.67%		32,2
24,1
33.64%		76,8
23,8
222.82%		32,8
30,3
8.35%
18,8


21,6


44,3


34,1


41,0


45,7

Announcement Date27/04/2331/07/2331/10/2331/10/2331/01/2425/04/2431/07/2431/10/2431/10/2431/01/25------

Upcoming sector events for Daiichi Sankyo Co., Ltd.

2025-02-09 SHILPA MEDICARE LIMITED: Q3 2025 Earnings Release
2025-02-09 ST PHARM CO.,LTD.: Q4 2024 Earnings Release
2025-02-09 NEULAND LABORATORIES LIMITED: Q3 2025 Earnings Release
2025-02-09 SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q3 2025 Earnings Release
2025-02-09 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release
2025-02-10 07:00 am ROIVANT SCIENCES LTD.: Q3 2024 Earnings Release
2025-02-10 ROYALTY PHARMA PLC: Q4 2024 Earnings Release
2025-02-10 LUPIN LIMITED: Q3 2025 Earnings Release
2025-02-10 MARKSANS PHARMA LIMITED: Q3 2025 Earnings Release
2025-02-10 ASTRAZENECA PHARMA INDIA LIMITED: Q3 2025 Earnings Release
More events

Past sector events for Daiichi Sankyo Co., Ltd.

2025-02-07 05:15 am SCINOPHARM TAIWAN, LTD.: January 2025 Sales and Revenue Release
2025-02-07 03:17 am ALKEM LABORATORIES LIMITED: Q3 2025 Earnings Release
2025-02-06 CALIWAY BIOPHARMACEUTICALS CO., LTD.: Q4 2024 Earnings Release
2025-02-06 FDC LIMITED: Q3 2025 Earnings Release (Projected)
2025-02-06 NIPPON SHINYAKU CO., LTD.: Q3 2024 Earnings Release
2025-02-06 MOCHIDA PHARMACEUTICAL CO., LTD.: Q3 2024 Earnings Release
2025-02-06 EISAI CO., LTD.: Q3 2024 Earnings Release
2025-02-06 TORII PHARMACEUTICAL CO., LTD.: Q4 2024 Earnings Release
2025-02-06 11:55 am SAI LIFE SCIENCES LIMITED: Q3 2025 Earnings Release
2025-02-06 09:26 am AUROBINDO PHARMA: Q3 2025 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4568 Stock
  4. Calendar Daiichi Sankyo Co., Ltd.